NCT01888731View on ClinicalTrials.gov

Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

September 30, 2010

Conditions
Healthy
Interventions
DRUG

Lamotrigine

Lamotrigine Extended Release Tablets, 25mg, 50mg, 100mg, 200mg and 300 mg

Trial Locations (1)

500 037

Bioserve Clinical Research Private Limited, Bālānagar

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY